Brief: Tcm Biotech International Corp - Receives FDA Breakthrough Device Designation For Catchimera Mrd Platform For Hcc

Tcm Biotech International

21/04/2026 13:50

Tcm Biotech International Corp 4169.TW:

TCM BIOTECH INTERNATIONAL CORP - RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR CATCHIMERA MRD PLATFORM FOR HCC

Source text: ID:nPnbn49m9a

Further company coverage: 4169.TW